Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of inhaled mannitol in bronchiectasis
2008-008731-28Phase 3Completed
- Sponsor
- Pharmaxis
- Start
- May 2009
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis comparing Inhaled mannitol with Placebo (2 arms). Primary endpoint: Pulmonary exacerbation rates (graded exacerbations). Started May 2009; status: completed.
02
Drugs
Bronchitol
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2008-008731-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008731-28.